Related Experiment Video
Updated: Oct 2, 2025
07:38
Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
3.9K
Mavacamten for hypertrophic cardiomyopathy: effectiveness and value
Molly Beinfeld1, Jason H Wasfy2, Surrey Walton3
1Institute for Clinical and Economic Review, Boston, MA.
Journal of Managed Care & Specialty Pharmacy
|February 24, 2022
Summary
This study evaluates the value of health care interventions. It provides evidence-based assessments to guide decision-making in healthcare.
Area of Science:
- Health economics and outcomes research
- Clinical effectiveness evaluation
- Healthcare policy analysis
Background:
- Independent health technology assessment is crucial for evidence-based healthcare decisions.
- The Institute for Clinical and Economic Review (ICER) provides objective evaluations of medical interventions.
- Understanding the value of healthcare interventions informs policy and resource allocation.
Purpose of the Study:
- To assess the clinical effectiveness and economic value of various health care interventions.
- To provide unbiased evidence to stakeholders including policymakers, payers, and providers.
- To support informed decision-making regarding the adoption and reimbursement of new therapies.
Main Methods:
- Systematic review and meta-analysis of clinical trial data.
- Health economic modeling to assess cost-effectiveness.
- Comparative effectiveness research comparing interventions.
Main Results:
- Varies depending on the specific intervention evaluated.
- Identifies interventions offering high value for money.
- Highlights areas where current treatments may be suboptimal.
Conclusions:
- Evidence-based assessments are vital for optimizing healthcare spending.
- ICER's framework promotes transparency and objectivity in value assessment.
- Informed decisions can lead to improved patient outcomes and sustainable healthcare systems.
More Related Videos
07:02Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
6.5K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.6K
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
56
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
78
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
01:30Cardiomyopathy II: Dilated Cardiomyopathy
48
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
48
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
77
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
77
01:22Mitral Valve Prolapse II: Assessment and Management
54
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
54
01:26Mitral Stenosis III: Medical Management
34
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
34